← Back to Clinical Trials
Recruiting NCT04300946

Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers

Trial Parameters

Condition Schizophrenia
Sponsor University Hospital, Strasbourg, France
Study Type OBSERVATIONAL
Phase N/A
Enrollment 48
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2021-10-10
Completion 2025-10-01
Interventions
TMS targeted on the cerebellum

Brief Summary

The aim of the study is to check the role of the cerebellum in time prediction in healthy volunteers, by means of magnetic transcranial stimulation targeted on the cerebellum, and recording of behavioural measures indexing time prediction

Eligibility Criteria

Inclusion Criteria: * Participant, male or female, between 18 and 60 years old * Subject affiliated to a social health insurance scheme (beneficiary or entitled person) * Subject who has dated and signed an informed consent form * For a woman of childbearing age, negative pregnancy test and effective contraception throughout the study Exclusion Criteria: * \- Participant with substance use disorders (as defined by DSM-V) * Participants taking benzodiazepines and related substances (in the period before inclusion, for a duration equivalent to 5 half-lives of the product), cannabis (in the 2 months before inclusion) or hallucinogenic substances (in the period before inclusion, for a duration equivalent to 5 half-lives of the product). * Participant with neurological pathology or sequelae * Participant with Attention Deficit Hyperactivity Disorder (ADHD) * Participant with a borderline personality disorder * Participant with disabling sensory impairments, including visual acuity (correcte

Related Trials